Clinical trial Recruiting at 1 site Observational Ages 18 and up

Three CT Signs of Nerve-Root Suffering in Low-Back Sciatica: How Often They Occur in Patients Referred for CT-Guided Nerve-Root Infiltration

Official title: Prevalence of Three CT Signs of Nerve-root Suffering (Root Size Asymmetry/Hypertrophy, Peri-radicular Infiltration, Spontaneous Hyperdensity) in Patients With Low-back Sciatica Referred for CT-guided Foraminal Infiltration: a Single-centre Retrospective Study (Nice University Hospital - Pasteur 2).

Run by Centre Hospitalier Universitaire de Nice · NCT07690449 · Data updated 2026-11-12

This study tests whether three specific CT signs align with the nerve root causing symptoms in adults with low-back sciatica who are scheduled for CT-guided nerve-root infiltration.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment400 (estimated)
SponsorCentre Hospitalier Universitaire de Nice
Academic / other
Locations1 site (Nice, Alpes Maritimes)
StatusRecruiting
StartedJanuary 30, 2024
Main results expectedMarch 4, 2026
Study endsOctober 1, 2026
Registry record updatedJuly 8, 2026
Trial IDNCT07690449 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18 and older with low-back sciatica/radicular pain referred for CT-guided foraminal or peri-radicular infiltration at Pasteur 2 Hospital in Nice within the specified dates, with interpretable pre-infiltration planning CT scans.

Probably not a fit

Patients without the three signs or with non-interpretable imaging may not gain information to guide treatment from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a retrospective, single-center observational study conducted at Nice University Hospital. It reviews pre-infiltration CT scans to see how often three signs (nerve-root size asymmetry, peri-radicular infiltration, and spontaneous root hyperdensity) appear near the clinically suspected nerve root. The goal is to determine if these signs correlate with the painful root and could help guide treatment planning for CT-guided procedures. Current data include 104 patients and 105 infiltrations, with about 16.8% showing all three signs and 38.6% showing at least two signs. The study analyzes scans from January 30, 2024, to July 11, 2024, with a target of 400 participants.

Why it matters

Potential benefit: If the signs reliably indicate the offending nerve root, this could improve planning for CT-guided infiltration and potentially reduce unnecessary procedures.

How similar studies have gone: Prior work in imaging signs for nerve-root involvement has shown variable associations; this study contributes retrospective, sign-focused data in a real-world clinical setting.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adult (\>= 18 years)
* Low-back sciatica / radicular pain with a systematized distribution
* Referred for CT-guided foraminal or peri-radicular infiltration at Pasteur 2 Hospital (Nice) between 30 Jan 2024 and 11 Jul 2024.
* Available and interpretable pre-infiltration planning CT

Exclusion Criteria:

* Planning CT missing or not interpretable
* Missing data on the three studied signs
* Radicular pain of tumoral, infectious or recent traumatic origin
* Spinal history precluding analysis of the studied root

Where it's running

  • Chu Nice
    Nice, Alpes Maritimes, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.